Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals

Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals

Vertex Pharmaceuticals (NASDAQ: VRTX) and Alexion Pharmaceuticals (NASDAQ: ALXN) are two major competitors in the healthcare sector, both of whom focus on developing drugs for rare diseases like cystic fibrosis and myasthenia gravis. Each company is profitable, makes around $5.45 billion in trailing revenue, and is rapidly growing its quarterly revenue.